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Global downregulation of microRNAs (miRNAs) is
commonly observed in human cancers and can
have a causative role in tumorigenesis. The mecha-
nisms responsible for this phenomenon remain
poorly understood. Here, we show that YAP, the
downstream target of the tumor-suppressive Hippo-
signaling pathway regulates miRNA biogenesis in
a cell-density-dependentmanner. At low cell density,
nuclear YAP binds and sequesters p72 (DDX17),
a regulatory component of the miRNA-process-
ing machinery. At high cell density, Hippo-mediated
cytoplasmic retention of YAP facilitates p72 associa-
tion with Microprocessor and binding to a specific
sequence motif in pri-miRNAs. Inactivation of the
Hippo pathway or expression of constitutively active
YAP causes widespread miRNA suppression in cells
and tumors and a corresponding posttranscrip-
tional induction of MYC expression. Thus, the Hippo
pathway links contact-inhibition regulation to miRNA
biogenesis and may be responsible for the wide-
spread miRNA repression observed in cancer.
INTRODUCTION
MicroRNAs (miRNAs) comprise a large family of regulatory RNAs
that repress expression of target messenger RNAs (mRNAs) and
have important roles in development and disease. Processing to
the mature 22 nucleotide miRNA is executed by the stepwise
cleavage of long primary miRNAs (pri-miRNAs) by the Micropro-
cessor and Dicer complexes (Figure S1A available online).
Microprocessor minimally comprises the ribonuclease DROSHA
and its double-stranded RNA-binding partner DGCR8 (Denli
et al., 2004; Gregory et al., 2004). Microprocessor recognizes
pri-miRNA through the stem loop (Zeng et al., 2005) and the
stem-loop-ssRNA junction (Han et al., 2006) and cleaves boththe 50 and 30 flanking segments to generate pre-miRNA. Various
cofactors can associate with Microprocessor (Fukuda et al.,
2007; Gregory et al., 2004; Siomi and Siomi, 2010). These regu-
latory proteins include hnRNP A1 (Guil and Ca´ceres, 2007), p68
and p72 (DDX5 and DDX17, respectively) (Fukuda et al., 2007),
Smad (Davis et al., 2008), KHSRP (Trabucchi et al., 2009),
BRCA1 (Kawai and Amano, 2012), and FUS/TLS (Morlando
et al., 2012). Microprocessor can also bemodulated by inhibitory
factors, including Lin28A/B (Piskounova et al., 2011), Musashi
homolog 2 (MSI2), and Hu antigen R (HuR) (Choudhury et al.,
2013), and NF90-NF45 (Sakamoto et al., 2009) binding to distinct
subsets of pri-miRNAs. Pre-miRNAs are exported to the
cell cytoplasm by exportin 5 (XPO5), where they are further
cleaved by a complex of the ribonuclease DICER and the dou-
ble-stranded RNA-binding protein TRBP2, generating mature
miRNA duplexes (Chendrimada et al., 2005). The 50 or 30 miRNA
is selected and loaded into the RNA-induced silencing complex
(RISC) that recognizes sites in the 30 untranslated region (UTR) of
target mRNAs to repress protein expression (Bartel, 2009).
Altered miRNA expression is a hallmark of cancer, and individ-
ual miRNAs can have either tumor-suppressive or oncogenic
functions. Furthermore, a prevailing feature observed in human
cancers is the global decrease in miRNA expression compared
to the corresponding normal tissue (Lee et al., 2008; Lu et al.,
2005; Maillot et al., 2009; Ozen et al., 2008; Thomson et al.,
2006). This miRNA suppression has a causative role in tumori-
genesis (Chang et al., 2008; Kumar et al., 2007, 2009), implying
its potential as a therapeutic target, but the underlying mecha-
nism is unknown. Importantly, widespread miRNA repression
in cancers is likely a result of defectivemiRNAprocessing, as evi-
denced by the accumulation of pri-miRNAs and the correspond-
ing depletion of mature miRNAs (Lee et al., 2008; Thomson et al.,
2006). Although rare mutations in Dicer (Hill et al., 2009), TRBP2
(Melo et al., 2009), and XPO5 (Melo et al., 2010) have been
reported, the pathways and mechanisms controlling miRNA
expression remain poorly understood.
To investigate how miRNA expression might be dysregulated
in tumors, we focused on the report that miRNA biogenesis is
affected by cell density (Hwang et al., 2009). These observationsCell 156, 893–906, February 27, 2014 ª2014 Elsevier Inc. 893
Figure 1. YAP Regulates Microprocessor Activity in a Cell-Density-Dependent Manner
(A–M) (A) qRT-PCR analysis of miRNA expression in HaCaT cells. Data were normalized to U6. *p < 0.05, Student’s t test. (B) Relative expression of pri-miRNAs
and DROSHA and DGCR8 at low and high densities. qRT-PCR data normalized to GAPDH. (C) Western blot analysis. (D) Schematic representation of the
(legend continued on next page)
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are especially relevant considering that loss of cell contact inhi-
bition is a common feature of tumor cells. Connecting these pre-
viously reported phenomena, we postulated that the observed
global miRNA repression in tumors might be related to the cell-
density-dependent regulation of miRNA biogenesis. We focused
on the Hippo-signaling pathway as a potential regulator of
cell-density-dependent miRNA biogenesis because (1) Hippo
pathway activity is highly sensitive to cell density and cell-cell
junctions (Kim et al., 2011; Schlegelmilch et al., 2011; Silvis
et al., 2011; Zhao et al., 2007); (2) the Hippo pathway regulates
the balance between differentiation and renewal of multiple
stem and progenitor cell types (Camargo et al., 2007; Lian
et al., 2010; Schlegelmilch et al., 2011); and (3) misregulation of
Hippo signaling is a common feature of human solid tumors
(Harvey et al., 2013; Zhao et al., 2010). The Hippo cascade is
emerging as an essential pathway for the regulation of tissue
homeostasis and organ size (Ramos and Camargo, 2012) and
is characterized by responsiveness to physiological cues such
as cellular crowding (Zhao et al., 2007), activation of G-protein-
coupled receptors (Yu et al., 2012), cell shape (Wada et al.,
2011), and mechanical forces (Dupont et al., 2011; Halder
et al., 2012). These cues culminate in differential subcellular
localization of the transcriptional coactivator YAP. At low cell
density, Hippo signaling is suppressed, and YAP localizes in
the nucleus, where it promotes cellular proliferation through tran-
scriptional mechanisms. As cellular crowding increases, cell-cell
contacts form and YAP is phosphorylated and sequestered in
the cytoplasm by adherens junction proteins E-cadherin (Kim
et al., 2011) and a-catenin (Schlegelmilch et al., 2011; Silvis
et al., 2011). Nuclear YAP induces the reversible overgrowth of
multiple organs and tumorigenesis in mice (Camargo et al.,
2007; Dong et al., 2007). Additionally, deregulation of the Hippo
pathway has been reported at a high frequency in a broad range
of different human carcinomas, and it often correlates with poor
patient prognosis (Harvey et al., 2013).
Here, we identify the Hippo-signaling pathway as a regulator
of Microprocessor activity. We show that YAP regulates miRNA
biogenesis through sequestering the Microprocessor compo-
nent p72 in a cell-density-dependent manner. We furthermore
find that perturbation of Hippo signaling causes widespread
miRNA suppression in cells and tumors and may underlie the
widespread miRNA repression in human tumors.
RESULTS
Hippo Pathway Component YAP Regulates
Microprocessor Activity in a Cell-Density-Dependent
Manner
To investigate the potential mechanism of cell-density-depen-
dent miRNA biogenesis and gain insight into global miRNA sup-
pression in tumors, we first characterized miRNA regulation inMicroprocessor (MP) reporter. TheDstem-loopmutant lacks the pre-miRNA stem
assays. (F) Expression levels of pri-, pre-, and mature miR-125b after indicated siR
for the pre- and mature miRNA. (G) Microprocessor reporter activity at different ce
analysis of YAP localization. YAP nuclear translocation was induced by knockdow
*p < 0.05, **p < 0.01, Student’s t test.
Data are represented as mean ± SEM. See also Figure S1.the nontransformed human keratinocyte HaCaT cell line. Consis-
tent with published data, we observed elevated miRNA expres-
sion at high cell density (Figures 1A andS1B, Hwang et al., 2009).
To avoid the selective loss of miRNAs with low GC content that
reportedly occurs when extracting RNA from a small number of
cells (Kim et al., 2012), we plated similar numbers of cells onto
plates of different sizes. This then allowed us to culture cells at
varying confluence without introducing the technical artifact
caused by different RNA yields. The corresponding pri-miRNAs
were upregulated at lower cell density (Figure 1B), implying a
general blockade of miRNA processing at lower cell density.
Expression of Microprocessor components DROSHA and
DGCR8 was not altered by cell density (Figures 1B and 1C), sug-
gesting that the activity, not the quantity, of Microprocessor may
underlie the altered miRNA biogenesis.
To assess Microprocessor activity in cells, we engineered a
luciferase reporter that utilizes portions of pri-miR-125b-1 or
pri-miR-205 embedded in the 30UTR of the Renilla luciferase
gene (Figure 1D). A similar approach to monitor Microprocessor
activity has been described (Tsutsui et al., 2008). Cleavage by
Microprocessor is expected to destabilize the Renilla luciferase
mRNA and to lead to decreased Renilla luminescence. We
measured Microprocessor activity by normalizing to the control
Firefly luciferase value so that the calculated values positively
correlated with the endogenous Microprocessor activity (Fig-
ure 1D). To validate these reporters, we measured response to
DROSHA or DGCR8 knockdown in HaCaT cells (Figures 1E
and S1C), where pri-miR-125b, but not pre-miR-125b, accumu-
lates and mature miR-125b is suppressed (Figure 1F). Validation
was also performed using Dgcr8 knockout mouse embryonic
stem cells (Figures S1D and S1E). The reporter was not affected
by knockdown of DICER or TRBP2 (Figure 1E). To further confirm
the specificity, we generated a control construct in which the
pre-miRNA stem loop was deleted (Figure 1D). Expression of
this reporter was unresponsive to depletion of Microprocessor
(Figure 1E). Altogether, these data verify that the reporter serves
as a sensitive readout of Microprocessor activity in cells.
Using the reporter system, we found that Microprocessor
activity was enhanced at higher cell densities compared to
lower-cell confluency (Figures 1G and S1F). To explore how
this cell-density-dependent Microprocessor activity could be
regulated, we focused on the Hippo-signaling pathway. YAP
localizes in the nucleus at low confluency and translocates to
the cytoplasm at high density (Figure 1H). This localization is
dependent on the upstream kinase LATS2 and other upstream
negative regulatory molecules such as the tumor suppressor
NF2. Inactivation of NF2 and LATS2 abrogated the cytoplasmic
sequestration of YAP at higher density (Figure 1H, ‘‘HD + siNF2/
LATS2’’). Using the Microprocessor reporter, we found that
knockdown of NF2 and LATS2 abrogated the enhanced Micro-
processor activity observed at high density (Figure 1I), implyingloop crucial for the recognition byMicroprocessor. (E) Microprocessor reporter
NA-mediated knockdown, normalized to GAPDH for the pri-miRNA and to U6
ll densities. *p < 0.05 versus empty, Student’s t test. (H) Immunocytochemistry
n of NF2 and LATS2. Scale bar, 30 mm. (I–M) Microprocessor reporter assays.
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that the Hippo pathway regulates Microprocessor activity. Addi-
tionally, forced expression of either YAP or a nuclear-targeted
phospho mutant YAP S127A repressed Microprocessor activity,
whereas overexpression of LATS2 resulted in enhanced reporter
activity, presumably through YAP phosphorylation and cyto-
plasmic retention (Figure 1J). Individual knockdown of NF2,
LATS2, or a-catenin had the reciprocal effect onMicroprocessor
activity (Figure 1K). We also tested Lats1- and Lats2-deficient
mouse embryonic fibroblasts (MEFs) generated by transducing
Lats1/;Lats2fl/fl MEFs with Cre-expressing adenovirus (Kim
et al., 2013, Figure S1G) and observed suppressed Micro-
processor reporter activity (Figure S1H) and lowered miRNA
expression (Figures S1I and S1J). We further examined the con-
sequences of YAP overexpression or knockdown at different cell
densities. Both forced YAP expression (Figure 1L) and YAP
knockdown (Figure 1M) abrogated the cell density dependency
of Microprocessor activity. Altogether, these results reveal that
the Hippo-signaling pathway and its downstream component
YAP regulate Microprocessor activity.
YAP Sequesters p72 from Microprocessor in a Cell-
Density-Dependent Manner
Wenext interrogated howYAP could control Microprocessor ac-
tivity. Because YAP has an established role as a transcriptional
coactivator, we first focused on the possible transcriptional
role of YAP (Yagi et al., 1999). Microarray analyses showed
that none of theMicroprocessor-related genes were significantly
affected by YAP activation (Figure S2A). To further rule out a
transcriptional role for YAP in Microprocessor regulation, we
made use of a YAP S94A mutant unable to bind the TEAD-family
of transcription factors (Schlegelmilch et al., 2011; Zhao et al.,
2008). YAP S94A and its nuclear-targeted version YAP S94A/
5SA suppressed Microprocessor activity to a similar extent as
their wild-type counterparts (Figure S2B). These results imply
that YAP regulates Microprocessor activity independent of its
transcriptional activity. We therefore focused on the possibility
that YAP might regulate Microprocessor posttranscriptionally.
We tested whether YAP might physically interact with Micro-
processor components. We did not detect an association be-
tween YAP and DROSHA or DGCR8 in coimmunoprecipitation
(co-IP) assays (Figure 2A). We next considered that YAP might
associate with the Microprocessor accessory proteins p68
(DDX5) and p72 (DDX17), DEAD (Asp-Glu-Ala-Asp)-box RNA
helicases that are components of a large DROSHA-containing
complex that is required for processing of a large subset of
miRNAs (Fukuda et al., 2007; Gregory et al., 2004). It is emerging
that several different cellular signaling pathways use the p68
and/or p72 association with Microprocessor to effect regulation
of pri-miRNA processing (Newman and Hammond, 2010; Siomi
and Siomi, 2010). Co-IPs indicated that p72, but not the structur-
ally similar p68, specifically associates with endogenous YAP
protein (Figure 2A).
Immunocytochemistry showed that YAP and p72 colocalize in
the nucleus of HaCaT cells at low density (Figure 2B) and not at
high density (Figure S2C).We assessed the impact of cell density
on this interaction by co-IPs with endogenous p72 protein.
At higher density, p72 interacted with DROSHA and DGCR8,
consistent with its role in pri-miRNA processing. Interestingly,896 Cell 156, 893–906, February 27, 2014 ª2014 Elsevier Inc.the interaction between p72 and DROSHA/DGCR8 complex
was significantly decreased at lower density and instead p72
was associated with YAP (Figure 2C). To gain deeper insight
into these cell-density-dependent interactions, we fractionated
cell lysates collected at low and high densities using a gel-filtra-
tion column. At high density, p72 eluted in the same fractions as
DROSHA and DGCR8, implying p72 association with the Micro-
processor complex (Figure 2D, ‘‘High density’’). Remarkably, at
low density, p72 was not detected in the same fractions as
DROSHA but was in the lower molecular weight fractions where
YAP was also eluted, implying the interaction of p72 and YAP at
low cell density (Figure 2D, ‘‘Low density’’).
This dynamic cell-density-dependent association of p72 with
Microprocessor raised the possibility that nuclear YAP might
inhibit Microprocessor activity at low cell density by binding
and sequestering p72 from DROSHA and DGCR8. Overexpres-
sion of the constitutively active YAP S127A mutant led to a
reduction in the relative amount of p72 associated with DROSHA
in co-IPs (Figures 2E–2G). Further analyses indicated that YAP
WW domain 1 (W177–W199) and p72 C-terminal proline-rich
sequence were essential for that interaction, whereas YAP WW
domain 2 and p72 K50 residue, which is required for HDAC1
interaction (Mooney et al., 2010), were not (Figures 2H and 2I).
We then tested YAP mutants with the Microprocessor reporter
system. YAPWWdomain mutant 1 (WW1) failed to inhibit Micro-
processor activity (Figure S2D). We knocked down p72 and
found that the density-dependent enhancement of Micropro-
cessor activity was abrogated in the Microprocessor reporter
system in a similar fashion as knockdown of NF2/LATS2 (Fig-
ure S2E). Combinatorial knockdown did not show any additive
effect. qRT-PCR analyses of pri-, pre-, and mature miR-125b
corroborated these results (Figure S2F). Taken together, the as-
sociation of p72 with Microprocessor is cell density dependent,
and nuclear YAP sequesters p72 through its WW1 domain at low
cell density to suppress Microprocessor activity.
We further explored whether the TEAD proteins were also part
of the protein complex containing YAP and p72. Co-IPs revealed
that the YAP/p72 complex does not contain TEAD1 (Figure S2G).
Additionally, we also observed interaction of TAZ, a YAP paralog,
with p72 (Figure S2H) (Dupont et al., 2011; Halder et al., 2012).
Forced expression of TAZ lowered mature miRNA expression
(Figure S2I), which was accompanied with increased pri-miRNA
expression (Figure S2J). Simultaneous knockdown of YAP and
TAZ had an additive effect on Microprocessor reporter activity
(Figures S2K and S2L). Thus, our results suggest a similar role
of TAZ in miRNA biogenesis and further implicate another
Hippo-signalingmolecule in the regulation of miRNA processing.
Inhibition of the Hippo-Signaling Pathway Suppresses
Microprocessor Activity
We next examined the significance of p72 and Hippo signaling
for Microprocessor function using a Microprocessor biochem-
ical assay (Figure 3A). We depleted DGCR8, p72, or NF2 and
LATS2 in a stable HEK293T cell line expressing Flag-DROSHA
(Figure 3B) and affinity-purified DROSHA-containing complexes
(Figure 3C). When NF2 and LATS2 were depleted (Figure 3B),
the amount of p72 associated with DROSHA was lowered
(Figure 3C), consistent with our findings in HaCaT cells. We
Figure 2. YAP Sequesters p72 from Micro-
processor Complex in a Cell-Density-
Dependent Manner
(A–I) (A) Coimmunoprecipitation assays (Co-IPs)
with endogenous YAP in HaCaT cells. (B) Immu-
nocytochemistry of YAP and p72 in HaCaT cells at
low density. Nuclei were stained with DAPI. Scale
bar, 30 mm. (C) Co-IP with HA-p72 in HaCaT cells
at low and high density. (D) Western blot analysis
of Superose 6 gel-filtration fractions. Whole-cell
lysates from HaCaT cells cultured at low and high
densities were fractionated. b-tubulin served as a
control. (E) Co-IP with Flag-DROSHA in HaCaT
cells transfected with YAP or control EGFP. (F)
Densitometry measurement for the amount of p72
bound by DROSHA in the HaCaT cells transfected
with YAP or control EGFP (n = 3). *p < 0.05, Stu-
dent’s t test. (G) The scheme of interactions
among YAP, p72, and Microprocessor. (H) Co-IP
with Flag-YAP and YAPmutants. Mutations in YAP
are represented in the top panel. WT, wild-type. (I)
Co-IP with HA-p72 and p72 mutants. Mutations in
p72 are represented in the top panel.
See also Figure S2.measured pri-miRNA processing activity of Microprocessor
isolated from control and knockdown cells. The p72-depleted
Microprocessor displayed compromised activity for pri-miR-
125b-1 (Figure 3D). Upon depletion of NF2 and LATS2, Micro-
processor activity was similarly impaired (Figure 3D). These
findings imply that p72 depletion and YAP activation have a
direct impact on pri-miRNA processing and strongly suggest
that the Hippo pathway regulates miRNA expression through
altering Microprocessor activity.Cell 156, 893–906,Global Impact of Hippo Pathway on
miRNA Biogenesis
Our data above would predict that Hippo
signaling inactivation and consequent
YAP nuclear translocation would result in
general miRNA suppression. We sought
to examine this by utilizing nCounter tech-
nology to profile >600 different miRNAs.
Indeed, NF2/LATS2 knockdown at high
cell density lowered (<0.8-fold compared
to siCtrl) 61.0% of miRNAs in HaCaT cells
(Figures4Aand4B).Wenext addressed to
what extent p72 explains global miRNA
repression by YAP activation. As a result,
59.8% of miRNAs were suppressed by
p72 knockdown, and 90.2% of p72-sup-
pressed miRNAs overlapped with siNF2/
LATS2-suppressed miRNAs. Quantifica-
tion by qRT-PCR validated the repression
of representative miRNAs (Figure 4C) and
the corresponding accumulation of pri-
miRNAs (Figure 4D). The expression of
miR-214, which is independent of p72 in
the mouse embryo (Fukuda et al., 2007),
was not affected by either p72 or NF2/LATS2 knockdown (Figure 4C). We further examined the role of
p72 as a mediator of miRNA repression via Hippo signaling by
testingwhether forcedexpressionofp72could rescueexpression
of thesiNF2/LATS2-suppressedmiRNAs. Indeed,p72expression
in addition to the siNF2/LATS2 transfection enhanced numerous
miRNAs (Figure S3A), suggesting that p72 positively regulates
global miRNA biogenesis downstream of NF2 and LATS2.
We next interrogated the cell-density-dependent global alter-
ation in miRNA expression. As reported in other types of cellsFebruary 27, 2014 ª2014 Elsevier Inc. 897
Figure 3. Hippo Pathway and p72 Regulate
Pri-miRNA Processing Efficiency of Micro-
processor
(A–D) (A) Scheme of the Microprocessor assay.
IVT, in vitro-transcribed. (B) Western blot analysis
showing the siRNA efficacies and expression of
Flag-DROSHA. (C) Western blot of purified protein
complexes. (D) Microprocessor assays with in-vi-
tro-transcribed pri-miR-125b. The numbers for
Microprocessor indicate the relative amounts of
Flag-IP products used for western blot (C) and
Microprocessor assay (D).(Hwang et al., 2009), HaCaT cells also showed widespread
variation of miRNA expression in a cell-density-dependent
manner. At lower cell density, 57.3% of miRNAs were sup-
pressed (<0.8 fold) relative to higher density (Figures 4E
and 4F). This density-dependent miRNA suppression could be
rescued by YAP knockdown (Figure S3B). To examine to what
extent this density-dependent miRNA modulation is regulated
by YAP and p72, we compared the miRNAs repressed in lower
density to the miRNAs repressed by p72 knockdown and NF2/
LATS2 knockdown. In this analysis, 49.3% of miRNAs overlap-
ped among the three conditions of NF2/LATS2 knockdown,
p72 knockdown, and low density (Figure 4G). Gene ontology
analysis revealed that the predicted mRNA targets for the over-
lapping miRNAs were highly enriched in cell-cycle control (Fig-
ure 4H). Together, our data support that the Hippo-signaling
pathway, through the YAP-mediated control of p72 availability,
is responsible for widespread cell density-dependent miRNA
regulation.
p72 Recognizes a Sequence Motif in Pri-miRNAs
p72 harbors a DEAD box domain and is regarded as an RNA heli-
case. Although p72 is essential for normal miRNA expression in
the developing mouse embryo (Fukuda et al., 2007), the precise
role of p72 in pri-miRNA processing is unknown. We sought to
dissect how p72 contributes to pri-miRNA processing. We hy-
pothesized that p72 might recognize a specific secondary struc-
ture or a sequence of pri-miRNAs to enhance the processing by
Microprocessor. Electrophoretic mobility shift assays (EMSA)
performed with recombinant p72 protein (Figure S4A) and
in vitro transcribed pri-miRNAs showed a stable interaction
between p72 and pri-miR-21 (Figure 5A) and pri-miR-125b-1
(Figure 5B). To examine the relevance of the secondary structure
of pri-miRNAs, we deleted the stem loop (Dstem loop), 50 flank-
ing segment (FS,D50), or 30 FS (D30) of pri-miR-21. The deletion of
the stem loop did not significantly affect the interaction, implying
that the recognition of pri-miRNA by p72 is independent of the898 Cell 156, 893–906, February 27, 2014 ª2014 Elsevier Inc.stem-loop structure (Figure 5C). The D50
mutant showed slightly impaired interac-
tion, but deletion of the 30 flanking
segment almost totally abolished the
interaction, suggesting that p72 interacts
through the 30 FS of pri-miR-21 (Fig-
ure 5C). Sequential shortening of the
30FS suggested that the distal part of
the 30 FS was dispensable (+81, +108, Figure 5D), though the
interaction was minimally impaired with the shortest mutant
(+55, Figure 5D). To test whether p72 recognizes a specific
sequence in the 30 FS of pri-miRNA, we searched for an overrep-
resented sequencemotif in the 30FS. As the input sequences, we
utilized pre-miRNA with 55 nt of 50 and 30 FS for the subset of
themiRNAs repressed by both p72 and NF2/LATS2 knockdown.
As the background data, those of nonsuppressed pre-miRNAs
were used. A VCAUCH sequence was identified in the 30 FS of
the subgroup of pri-miRNAs that are repressed by both p72
and NF2/LATS2 knockdown (Figure 5E). The motif was present
at +19 and +16 of 30 FS of pri-miR-21 and pri-miR-125b-1,
respectively (Figure 5F). We examined the functional relevance
of the motif by introducing mutations in the motif (Figure 5G,
‘‘motif mutant’’) or in the adjacent sequence (Figure 5G, ‘‘control
mutant’’). EMSA revealed an impaired interaction of p72 with the
motif mutant, demonstrating the functional relevance of themotif
in the 30 FS of pri-miR-21 (Figure 5H). To further test the rele-
vance of the motif sequence in a cellular context, we induced
deletion mutations to the Microprocessor reporter plasmid.
Deletions of the motif sequence significantly impaired the den-
sity sensitivity of the Microprocessor reporter (Figure S4B) and
reduced the responsiveness to YAP activation through NF2/
LATS knockdown (Figure S4C). These findings suggest that
p72 selectively binds the defined sequence in the 30 FS of pri-
miRNAs to enhance processing by the Microprocessor.
YAP-Regulated miRNAs Target MYC
Although global miRNA suppression is suggested to have a
causal role in tumorigenesis, the specific mechanisms underly-
ing this are not fully understood. We considered that repression
of a certain subset of miRNAs by YAP might lead to posttran-
scriptional enhancement of target gene(s) crucial for tumorigen-
esis and growth. To examine this, we established aHaCaT stable
cell line expressing a YAP 5SA mutant in a doxycycline (Dox)-
inducible manner. YAP 5SA has four serine residues substituted
Figure 4. Global Impact of Hippo Pathway on miRNA Biogenesis
(A–G) (A) Global miRNA expression analysis of HaCaT with indicated knockdown. The miRNAs with a relative expression change of <0.8-fold or >1.2-fold
compared to the control (siCtrl) were analyzed by hierarchical clustering. (B) The efficacy of siRNAs used in (A). The expression valueswere normalized toGAPDH.
(C) qPCR-quantification of mature miRNAs normalized to U6. (D) Pri-miRNA expression levels measured by qRT-PCR. Data were normalized to GAPDH. (E)
miRNA expression analysis in RNA samples from low- and high-density HaCaT cells. miRNAs with a relative expression change of <0.8-fold or >1.2-fold between
the low- and high-density conditions were analyzed by hierarchical clustering. (F) Scatter plot of miRNA expression levels (log10) in the low and the high densities.
(G) Venn diagram showing the overlap of miRNAs repressed by siNF2/LATS2, si p72, or low density. (H) Gene ontology analysis of the overlapping miRNAs in (G).
Bonferroni-corrected p values were indicated. Data are represented as mean ± SEM. See also Figure S3.to alanine in addition to S127, and it displays enhanced nuclear
localization (Zhao et al., 2007). After Dox treatment for 4 days,
YAP and YAP target genes CTGF, CYR61, and AMOTL2 were
induced without affecting the mRNA levels of MYC (Figure 6A).
Numerous mature miRNAs were repressed (Figures 6B and
6C) with a corresponding accumulation or sustained pri-miRNAexpression (Figures 6D and S5A). Among the growth-related
proteins tested, we found enhanced expression of MYC protein
(Figure 6E) after YAP induction. MYC induction was also
observed in HaCaT cell lines inducibly expressing YAP S94A
and YAP S94A/5SA, suggesting that MYC was posttranscrip-
tionally induced (Figures 6F and S5B).Cell 156, 893–906, February 27, 2014 ª2014 Elsevier Inc. 899
Figure 5. p72 DEAD Box RNA Helicase Binds to a Sequence Motif in the 30 Flanking Segment of Pri-miRNA
(A–H) (A–D) EMSAwith recombinant p72 protein and in-vitro-transcribed pri-miR-21, pri-miR-125b-1, or deletion mutants of pri-miR-21. Stem loop (Dstem-loop),
50 flanking segment (D50 ) or 30 flanking segment (D30) were deleted. (E) Identification of a sequence motif in the miRNAs repressed by knockdown of both NF2/
LATS2 and p72. (F) Schematics showing the motif in the 30 flanking segments of pri-miR-21 and pri-miR-125b-1. (G) Pri-miR-21 schematic indicating the motif
mutations introduced and the control mutant. Arrowheads indicate cleavage sites by the Microprocessor. (H) EMSA with recombinant p72 protein and the +55
mutant, the control mutant, and the motif mutant of the pri-miR-21.
See also Figure S4.To further examine the YAP-mediated posttranscriptional
induction of MYC, we investigated the relevance of the MYC
30UTR, which contains potential targeting sites for several
miRNAs that were repressed by YAP overexpression and p72
depletion (Figure S5C). Among them, let-7 (Kumar et al., 2007)
and miR-34a (Christoffersen et al., 2010) were reported to target
MYC 30UTR. We utilized a luciferase gene harboring the MYC
30UTR (Kumar et al., 2007) and compared luciferase activity to
a control plasmid. YAP 5SA overexpression induced luciferase
activity >10-fold compared to a control EGFP (Figure 6G).
TEAD-binding-deficient YAP mutants, YAP S94A and YAP900 Cell 156, 893–906, February 27, 2014 ª2014 Elsevier Inc.S94A/5SA, also strongly activated the luciferase reporter, rein-
forcing the role of YAP in the posttranscriptional regulation of
MYC expression (Figure 6G). The activity of Luc-MYC 30UTR
was also suppressed at higher cell density and correlated with
the accumulation of miRNAs targeting MYC (Figure 6H). Knock-
down of p72 at higher cell density rescued the repression of lucif-
erase activity, suggesting that cell-density-dependent regulation
of MYC 30UTR was mediated by p72 (Figure 6H). Collectively,
the posttranscriptional induction of MYC protein is a func-
tional outcome of YAP-mediated cell-density-dependent global
miRNA repression.
Figure 6. YAP-Regulated miRNAs Repress MYC Expression
(A–H) (A) qRT-PCR analysis with data normalized to GAPDH. (B) miRNA northern blot performed with spike-in of luciferase siRNA for normalization. (C) qRT-PCR
analysis of mature miRNA levels normalized to U6. *p < 0.05, Student’s t test. (D) Relative pri-miRNA expression measured by qRT-PCR normalized to GAPDH.
(E and F) Western blot analysis using indicated antibodies. (G and H) Luciferase assays with a MYC 30UTR reporter. HaCaT cells were cotransfected with the
luciferase and the expression plasmids for YAP or control EGFP. Luciferase activity was normalized to that of pRL-Tk.
**p < 0.01, Student’s t test. n.s., not significant. Data are represented as mean ± SEM. See also Figure S5.YAP Mediates Global miRNA Suppression in Tumors
A large number of solid human cancers demonstrate impaired
Hippo signaling and exhibit constitutive nuclear YAP localization
(Harvey et al., 2013). Additionally, YAP activation leads to rapid
tumor development in mice (Benhamouche et al., 2010;
Camargo et al., 2007; Dong et al., 2007; Schlegelmilch et al.,
2011; Zhang et al., 2010). Our findings in vitro imply that YAP-
driven tumors might exhibit global miRNA repression. We tested
this prediction in mouse models of YAP-induced tumorigenesis.
We evaluated this in two distinct contexts of YAP activation:
acute (8 days) YAP induction in the epidermis (Figure 7A) and
chronic (50 weeks) YAP activation in the liver (Figure 7G).
Short-term expression of a transgenic YAP S127A in the Kera-
tin-14-positive (K14+) epidermal progenitor cells induces in situ
squamous cell carcinoma-like tumors in mice, which can pro-
duce invasive growth upon transplantation into nude mice
(Schlegelmilch et al., 2011). Gene expression analyses of the
oncogenic epidermal cells revealed potent induction of trans-
genic YAP S127A (hYAP, Figure 7B) and YAP target genes (Fig-
ure 7C). As predicted, YAP induction led to the repression of
numerous mature miRNAs (Figure 7D) and the accumulation of
pri-miRNAs (Figure 7E), recapitulating our in vitro findings.
Global analysis revealed that 52.5% of miRNAs were sup-
pressed at least 0.8-fold in the tumorigenic cells as compared
to the normal epidermal cells (Figure 7F).The liver tumor model relied on hepatocyte-specific deletion
of Nf2 in adult mice (Figures 7G and 7H). This resulted in
hepatomegaly, cholangiocarcinoma-like tumor formation (Fig-
ure S6A–S6C), and induction of YAP target genes (Figure 7I).
The expression of mature miRNAs was repressed in the liver
tumors compared to control tissue (Figure 7J), which was
accompanied by the accumulation of pri-miRNAs in the tumors
(Figure 7K). The miRNA global analysis revealed that 61.0% of
miRNAs were repressed in the liver tumors as compared to
normal tissue (Figure 7L). To explore the relevance of p72 in
the context of YAP-induced tumorigenesis, we examined the as-
sociation of p72 with Microprocessor and YAP. Co-IP revealed
that the interaction between p72 and Microprocessor observed
in normal livers was significantly decreased in tumor tissues,
whereas the association between p72 and YAP was increased
in Nf2-deficient tumors (Figure 7M). The interaction between
p72 and YAP was also observed in the skin tumors (Figure S6D).
Overall these results demonstrate that YAP-driven tumorigen-
esis is associated with widespread miRNA suppression and
that YAP activation promotes the dissociation of p72 fromMicro-
processor complex in tumor cells.
Finally, we examined whether this transcription-independent
function of YAP plays a causative role in cellular growth. We
chose to study the consequences of expressing the TEAD-bind-
ing defective mutant YAP S94A/5SA, given that current dogmaCell 156, 893–906, February 27, 2014 ª2014 Elsevier Inc. 901
(legend on next page)
902 Cell 156, 893–906, February 27, 2014 ª2014 Elsevier Inc.
suggests that most of YAP’s effects are mediated by tran-
scription through the TEAD proteins. YAP S94A/5SA repressed
miRNAs with the p72-binding motifs (Figure S6E) and also
showed significant acceleration of cell growth in HaCaT cells,
though this effect was less potent than that of YAP 5SA. Coex-
pression of p72 in this cellular context fully counteracted
the effect of YAP S94A/5SA (Figure S6F). A similar effect was
observed in HepG2 human hepatocellular carcinoma cells,
where YAP S94A/5SA expression significantly promoted their
anchorage-independent growth in a p72-dependant manner
(Figures S6G and S6H). Our results here support a functional
role for YAP in mediating cellular proliferation independent of
its canonical transcriptional partners and dependent on the
Microprocessor component p72.
DISCUSSION
Here, we uncover an unexpected role for the Hippo-signaling
pathway in the regulation of miRNA biogenesis. Our results pro-
vide mechanistic understanding for two unexplained phenom-
ena: cell-density-dependent activation of miRNA biogenesis
and widespread decrease in miRNA expression in tumors
(Hwang et al., 2009; Lu et al., 2005). We found that YAP, the
downstream Hippo-signaling transducer, induces widespread
miRNA repression by sequestering p72 from theMicroprocessor
in a cell-density-dependent manner (Figure 7N). At low cell den-
sity, YAP is nuclear, promotes cell proliferation, and represses
miRNA biogenesis. At higher cell density, YAP is inactivated
by exclusion from the cell nucleus, thereby allowing p72 to
associate with Microprocessor and pri-miRNAs, resulting in
enhancedmiRNA biogenesis. The association of the related pro-
tein, p68 (DDX5), with the Microprocessor is also dynamically
regulated. p68 is directly phosphorylated by MAPK-activated
protein kinase 2 (MK2), and p68 phosphorylation is necessary
for its nuclear localization (Hong et al., 2013). Therefore, an
emerging theme for controlling Microprocessor activity is
through the accessibility of these related cofactors either by
phosphorylation-dependent control of nuclear localization (for
p68) or through the sequestration of p72 in the nucleus by
YAP. Cell signaling pathways can impact other components of
the miRNA biogenesis machinery, including the mitogen-acti-
vated protein kinase (MAPK) Erk-mediated phosphorylation
of TRBP (Paroo et al., 2009) and the epidermal growth factor
receptor (EGFR)-mediated phosphorylation of Ago2 (Shen
et al., 2013).
p72 enhances pri-miRNA processing by the Microprocessor
and recognizes a VCAUCH sequence motif in the pri-miRNA 30
flanking region (30FS). A recent in vitro selection and high-
throughput sequencing approach for functional pri-miRNAFigure 7. YAP Mediates the Global Repression of miRNA Biogenesis in
(A–N) (A) Mouse model of YAP-induced skin tumorigenesis. (B) Expression of exog
isolated epidermal cells. (C) Expression levels of YAP target genes normalized to
Student’s t test. (E) Expression levels of the pri-miRNAs normalized to Hprt1. (F) G
liver. (H) Expression levels of mouse Yap normalized to Hprt1. (I) The expression
levels normalized to sno142. *p < 0.05, Student’s t test. (K) Relative expression lev
tissues. (M) Co-IP with p72 in the normal tissues and tumors from the mouse live
Data are represented as mean ± SEM. See also Figure S6.variants or for Microprocessor-binding variants of human pri-
miRNAs identified a CNNC motif in the 30FS conserved among
vertebrates for a large subset of human pri-miRNAs. This func-
tional motif, located 16–20 nt downstream of the Drosha
cleavage site is required for efficient pri-miRNA processing and
overlaps with the p72-binding motif that we identified. In that
study, the authors identified SRp20/SRSF3 as a factor that binds
the CNNCmotif. Although the relevance of this splicing regulator
in miRNA biogenesis was not tested, it is possible that multiple
different factors may converge at this 30 FS site to mediate pri-
miRNA processing. It will be interesting to examine the interplay
between p72 and other possible regulators in miRNA biogenesis
(Auyeung et al., 2013).
The mechanism that we characterized represents a unique
transcription-independent function of the YAP protein. YAP
has another transcription-independent role in the growth control
of intestinal stem cells, where YAP sequesters Dishevelled pro-
tein in the cytoplasm, thereby repressing Wnt signaling (Barry
et al., 2013). The major transcriptional role of YAP is mediated
through TEAD DNA-binding proteins (Zhao et al., 2008), and
therefore YAP S94A, which is deficient in TEAD binding, has a
deficit in the transcription of crucial target genes. The finding
that YAP S94A and its nuclear-targeted version YAP S94A/5SA
repressed Microprocessor activity provides evidence that YAP
represses miRNAs independent of its transcriptional activity.
Furthermore, YAP can induce cellular proliferation independent
of TEAD and can be rescued by p72. MYC globally suppresses
miRNA through transcription (Chang et al., 2008). Our findings
cannot be explained by the transcriptional repression of miRNA
by MYC because we observe accumulation of pri-miRNAs and
corresponding decrease in mature miRNAs upon manipulation
of the YAP/p72/Microprocessor pathway. Also, this posttran-
scriptional control of miRNA biogenesis corresponds well with
the reported widespread blockade of pri-miRNA processing
observed in various human cancers.
Cell proliferation and differentiation need to be coordinated for
the dynamic control of organ growth and repair. The molecular
and cellular mechanisms responsible for integrating these pro-
cesses remain poorly understood. Because the Hippo-signaling
pathway plays an important role in organ size control, it will be of
interest to examine the relevance of miRNA expression changes
in that context. Elevated miRNA expression likely serves to
repress cell proliferation and promote cell differentiation (Kanel-
lopoulou et al., 2005; Yi et al., 2009). Failure of this switchingmay
lead to uncontrolled cell expansion and widespread repression
of miRNAs, which are hallmarks of tumors. Our findings that
the Hippo pathway synchronizes cellular expansion and miRNA
biogenesis illuminate the potential for new therapeutics that
target miRNA biogenesis for the treatment of human cancers.Tumors
enous human YAP S127A and endogenous mouse Yap normalized to Hprt1 in
Hprt1. (D) Mature miRNA expression levels normalized to sno142. *p < 0.05,
lobal miRNA analysis. (G) Mouse model of YAP-induced tumorigenesis in the
levels of YAP target genes normalized to Hprt1. (J) Mature miRNA expression
els of the pri-miRNAs normalized to Hprt1. (L) Global miRNA analysis in the liver
rs. (N) Proposed model.
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EXPERIMENTAL PROCEDURES
Cell Lines
HaCaT cells were cultured in DMEM + 10% FBS. At low density, cells existed
as single cells or small colonies. For high-density conditions, similar numbers
of cells were seeded in a smaller culture dish than the low-density condition
and were cultured to reach confluency. Percent confluence was estimated
by microscopic observation. pInducer20 (Meerbrey et al., 2011) -YAP 5SA,
-YAP S94A, or -YAP S94A/5SA was transduced to generate doxycycline
(Dox)-inducible HaCaT and HepG2 cell lines. The transduced cells were
selected with G418 (400 ng/ml) for 2 weeks. For YAP induction, Dox was
added at 1000 ng/ml for 4 days. HEK293T-Flag-DROSHA cells (Gregory
et al., 2004) were cultured in DMEM + 10% FBS with puromycin (2 mg/ml).
For proliferation assays, cells were plated at 1.5 3 105 cells/ml in triplicate in
6-well plates and were counted at the indicated time points. SV40 LT-immor-
talized Lats1/;Lats2fl/fl MEFs were described previously (Kim et al., 2013).
For Lats2 deletion, Ad5-CMV-Cre (Gene Transfer Vector Core, University of
Iowa) was infected.
Plasmids
Plasmids for YAP, YAP S127A, WW1-, WW2-, WW1/WW2 mutants, DC, and
a-catenin were described previously (Schlegelmilch et al., 2011). Plasmids
for YAP S94A, S94A/5SA (Zhao et al., 2008), HA-p72-WT, and K50R (Mooney
et al., 2010) were kindly provided. pRL-MYC-30UTR (Kumar et al., 2007) was
from Addgene (Plasmid 14806). Luciferase assays were performed using
dual-luciferase reporter system (Promega). Lipofectamine 2000 (Invitrogen)
was used for transfections.
Microprocessor Reporter
For the Microprocessor reporter, the human pre-miR-125b stem loop with the
flanking upstream and downstream sequences were inserted to the 30 UTR of
Renilla luciferase gene in psiCHECK2 plasmid (Table S1). For themutated con-
trol (Dstem loop), the stem loop was deleted (Table S1). For themotif deletions,
GCATCC (+16 to +21 in the 30FS, ‘‘Dmotif’’) or the proximal sequence of 30FS
(+1 to +65 in the 30FS, ‘‘Dproximal’’) was deleted.
Gene Expression Analysis
For miRNA, RNA extraction was with TRIzol (Invitrogen). TaqMan miRNA
assays (Applied Biosystems) were used to quantify mature miRNA expres-
sion. Pri-miRNA levels were analyzed by qPCR using Fast SYBR Green
Master Mix (Applied Biosystems). For pre-miRNA quantification, small
RNAs were enriched using mirVana (Ambion). Primers used for qPCR
are listed in Table S2. TaqMan probes (Applied Biosystems) were used
for mRNA quantification. For knockdown experiments, Lipofectamine
RNAiMAX (Invitrogen) was used to transfect siRNAs (sequences in Table
S3) at 10 nM.
Northern Blot
Total RNA was isolated from 5 3 105 cell HaCaT cells cultured at either low
or high densities. 100 fmoles of control RNA (GL2 siRNA, 50- CGUACGCG
GAAUACUUCG-30) was spiked into cell lysates. Northern blots were per-
formed as described (Gregory et al., 2004).
Immunoprecipitation and Western Blot
Cells were lysed with NETN buffer (100 mM NaCl, 20 mM Tris-Cl (pH 8.0),
0.5 mM EDTA, 0.5% Nonidet P-40). After centrifugation at 20,000 3 g at
4C for 5 min, lysates were pretreated with Protein A/G Sepharose beads
(Sigma) and incubated with antibodies at 4C overnight. The protein-antibody
complexes were incubated with protein A/G sepharose at 4C for 1 hr. For the
IP with Flag or HA tag, the pretreated lysates were incubated with anti-Flag
M2 Affinity Gel (A2220, Sigma-Aldrich), EZview Red Anti-HA Affinity Gel
(Sigma), or control IgG AC (Santa Cruz) at 4C for 1 hr. The beads were
washed three times with NETN 200 buffer (200 mM NaCl, 20 mM Tris-Cl
[pH 8.0], 0.5 mM EDTA, and 0.5% Nonidet P-40). The sample buffer was
added and incubated at 95C for 5 min. After centrifugation at 20,000 3 g
for 1 min, the supernatants were collected for western blot analysis using
antibodies in Table S4.904 Cell 156, 893–906, February 27, 2014 ª2014 Elsevier Inc.Fractionation of Protein Complexes
Whole-cell lysates of HaCaT cells cultured at the low and high densities were
fractionated with Superose 6 gel filtration column as described previously
(Gregory et al., 2004). Fractions from the gel-filtration chromatography were
concentrated with Amicon Ultra centrifugal filters (Millipore) and analyzed by
SDS-PAGE and western blot.
Immunocytochemistry
HaCaT cells were fixed with 4% paraformaldehyde for 10 min at RT, permea-
bilized with 0.1% Triton X-100 for 1 min at RT, blocked with 2% FBS, and incu-
bated with antibody against YAP (1:200, Cell Signaling, #4912) and p72 (1:200,
Bethyl Laboratories, A300-509A) at 4C overnight. After washing PBS, cells
were incubated with anti-mouse-Alexa Fluor 488 and anti-rabbit-Alexa Fluor
546 (1:1,000, Invitrogen). Nuclei were stained with DAP (Invitrogen).
Microprocessor Assay
Microprocessor was purified from HEK293T-Flag-DROSHA stable cell line
96 hr after transfection of siRNA for NF2, LATS2, p72, or DGCR8, or negative
control. In vitro transcription of pri-miR-21 and miR-125b-1 and Micropro-
cessor assays, using affinity-purified Flag-Drosha complexes was performed
as described previously (Gregory et al., 2004).
miRNA Global Expression Analysis
nCounter miRNA assay (nanoString, Geiss et al., 2008) was used for global
miRNA analysis. miRNAs with normalized expression levels more than those
of negative control probes were analyzed. ThemiRNA expression was normal-
ized to all miRNAs except for liver analysis, which was normalized with the top
100 genes. For hierarchical clustering analysis, the normalized values for each
miRNA were z transformed and Multiple Experiment Viewer (Saeed et al.,
2006) was used for computing the complete linkage hierarchical clustering
algorithm with the Pearson correlation metric. The gene ontology enrichment
analyses for miRNAs were performed with starBase (Yang et al., 2011).
Bonferroni-corrected p values were presented.
Motif Analysis
For discovering potential p72 recognition sites in the pri-miRNA, the
pre-miRNA sequences with flanking regions 55 nt upstream and 55 nt
downstream were obtained from the Ensemble database. The sequences
were analyzed with Improbizer (http://users.soe.ucsc.edu/kent/improbizer/
improbizer.html) sequence logos were generated using WebLogo (Crooks
et al., 2004).
Recombinant p72 Protein Purification and EMSA
His-tagged p72 was expressed and purified from BL21-CodonPlus Compe-
tent bacteria (Stratagene). EMSA with internally labeled pri-miR-125b, pri-
miR-21, or mutated pri-miR-21 (sequences in Table S5) was performed in
binding buffer (50 mM Tris [pH 7.5], 100 mMNaCl, 10 mM 2-mercaptoethanol,
20 U RNasin [Promega], 1 mM ATP) with 1 nM pri-miRNA and incubating for
45 min at RT. Bound complexes were resolved on native 3.5% polyacrylamide
gels and visualized by radiography.
Soft Agar Assay
HepG2 cell lines were suspended in DMEM with 10% FBS, 0.3% SeaPlaque
agarose (Lonza, #50101), and 1,000 ng/ml Dox and were plated at 3,000
cells/well in a 6-well culture dish on a layer of 0.6% agar containing the
same medium. DMEM with 10% FBS and 1000 ng/ml Dox was added on
the gels. Cell colonies were stained with crystal violet after 14 days in culture
and quantified with Image J.
Mouse Models
Mouse experiments were approved by the BCH Animal Care and Use Com-
mittee and were performed in accordance with all relevant guidelines and
regulations.
Skin Tumorigenesis Model
Adult R26stoprtTA/+ Col-tetO-YAPS127A/+ K14-Cre (‘‘+Cre’’ group) and
R26stoprtTA/+ Col-tetO-YAPS127A/+ (‘‘-Cre’’ control group, n = 6) were treated
for 8 days with Dox (1 mg/ml) administered in drinking water. The epidermal
cells, which are enriched for the skin progenitor cells, were collected as
described (Schlegelmilch et al., 2011).
Liver Tumorigenesis Model
Nf2fl/fl (Benhamouche et al., 2010) female mice (n = 3) were administered
PBS or AAV2/8-Cre (AV-8-PV1091, University of Pennsylvania Vector Core,
MOI = 1011) to induce hepatocyte-specific deletion of Nf2 gene. Livers were
inspected after 50 weeks tumors were collected for analysis.
Statistical Analysis
For all quantified data, mean ± SEM is presented. Statistical significance be-
tween two experimental groups is indicated by an asterisk, and comparisons
were made using the Student’s t test. p values less than 0.05 were considered
significant.
ACCESSION NUMBERS
The GEO accession numbers for nCounter and microarray analyses are
GSE52276 and GSE49384.
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